Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_assertion type Assertion NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_head.
- NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_assertion description "[This mechanism of PBP binding, including inhibition of PBP2a, confers broad-spectrum activity against clinically important Gram-negative and Gram-positive pathogens, including MRSA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_provenance.
- NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_assertion evidence source_evidence_literature NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_provenance.
- NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_assertion SIO_000772 18318877 NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_provenance.
- NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_assertion wasDerivedFrom befree-2016 NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_provenance.
- NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_assertion wasGeneratedBy ECO_0000203 NP658856.RA62m6lkrl7VJL8DysFNmlQU-ws6s4QYglUyq7x4FeaQA130_provenance.